1.
Potential benefits of novel agent Tanshinone in the management of oral submucous fibrosis. J Orofac Res [Internet]. 2020 May 3 [cited 2025 Apr. 28];9(2):20-3. Available from:
https://mansapublishers.com/index.php/jofr/article/view/2321